Skip to main content

Featured

Tariff Ultimatum on Iran Trade Sparks Global Tension

                                                Doing Business With Iran? Trump Says Pay a 25% US Tariff. A new 25% tariff threat from President Donald Trump has sent a jolt through international markets, after he declared that any nation continuing to trade with Iran would face steep U.S. penalties. The announcement, delivered abruptly through social media, signaled a sharp escalation in Washington’s effort to isolate Tehran economically. The move comes amid heightened criticism of Iran’s internal crackdown on dissent, which U.S. officials argue warrants stronger international pressure. By targeting not just Iran but its trading partners, the administration aims to force countries—including major global players—to reconsider their economic ties with Tehran. The threat immediately stirred uncertainty across global markets. Oil prices climbed...
Post a Comment
Read more

article

Labels

Pharmacare in Canada: A Dream or a Reality?

 


The fate of Canada's pharmacare plan is uncertain as the federal government faces challenges in implementing a universal drug coverage program, even if a bill to create one passes in Parliament. Bill C-213, the Canada Pharmacare Act, aims to establish a national framework for pharmacare that would ensure all Canadians have access to prescription drugs based on their medical needs, not their ability to pay. 

However, the bill does not specify how the program would be funded, administered or negotiated with the provinces and territories, leaving many questions unanswered about the feasibility and cost-effectiveness of pharmacare. Some experts and stakeholders have expressed doubts about whether Ottawa has the political will, the constitutional authority and the fiscal capacity to deliver on its promise of pharmacare, especially in the wake of the COVID-19 pandemic that has strained the health care system and the public purse.

Labels:

Comments

Post a Comment